Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
05/2001
05/23/2001EP1100519A1 Multibinding agents that modulate nmda receptors
05/23/2001EP0689536B1 Naphthalene derivatives
05/23/2001CN1066135C Synthesized excitatory amino acid
05/22/2001US6235770 Anticholesterol agents
05/22/2001US6235768 Osteoporosis; rheumatic disorders; antitumor agents
05/22/2001US6235765 Benzimidazole derivatives
05/22/2001US6235271 UV-protection formulation
05/17/2001WO2001034578A1 Compounds with anti-helicobacter pylori activity
05/17/2001WO2001034573A1 Compounds
05/17/2001WO2001034572A2 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors
05/17/2001WO2001005390A3 Method for treating chronic pain using mek inhibitors
05/17/2001DE19953899A1 Carboxamid-substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Carboxamide-substituted benzimidazole derivatives, processes for their preparation and their use as medicaments
05/16/2001EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/16/2001CN1295071A Condensed imidezo-[1,2-a] pyridines
05/15/2001US6232334 Benzimidazole derivatives, their production and use
05/10/2001WO2001032634A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
05/10/2001WO2001032630A1 Oligobenzimidazole derivatives and their use as dna transfection agents
05/10/2001WO2001032174A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists
05/10/2001WO2001032171A1 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline nmda/nr2b antagonists
05/10/2001DE19951960A1 Verfahren zur Herstellung von Ulkustherapeutika A process for preparing Ulkustherapeutika
05/10/2001CA2389778A1 Oligobenzimidazole derivatives and their use as dna transfection agents
05/10/2001CA2389259A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists
05/10/2001CA2389234A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
05/10/2001CA2389184A1 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline nmda/nr2b antagonists
05/09/2001EP1097926A1 Thiobenzimidazole derivatives
05/09/2001EP1097127A1 Diacylhydrazine derivatives as integrin inhibitors
05/09/2001EP0813519B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
05/09/2001CN1294583A Herbicidal 2-(5-isoxazolinyl methyloxyphenyl)-4,5,6,7-tetrahydro-2h-indazole derivatives
05/08/2001US6228881 Aromatic heterocyclic compounds and their use as anti-inflammatory agents
05/03/2001WO2001030765A2 Method for producing therapeutic agents for ulcers
05/03/2001WO2001030761A1 Heterocyclically substituted benzoylguanidine, method for the production thereof, the use thereof as a medicament or means of diagnosis and a medicament containing the same
05/02/2001EP1095037A1 Improved process of synthesis of 5-methoxy- 2- (4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl]sulfinyl-1h-benzimidazole
05/02/2001EP1095025A2 Benzimidazoles, production thereof and use thereof as medicaments
05/02/2001EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/02/2001EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
05/02/2001EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
05/02/2001EP1094816A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
05/02/2001EP1094812A1 Angiogenesis inhibitors
05/02/2001EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
05/02/2001EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
05/02/2001EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/01/2001US6225331 For therapy and prophylaxis nasal congestion, otitis media, and sinusitis, treating cough, chronic obstructive pulmonary disease (copd) and/or asthma, benign prostatic hypertrophy, cardiovascular disorders, glaucoma, hyperemia, conjunctivitis
04/2001
04/26/2001WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/26/2001DE19950898A1 New heteroaryl substituted fluoroalkyl-benzoylguanidine derivatives useful for treatment of e.g. ischemias, cardiac infarction, angina, shock, atherosclerosis, cancer and metabolic disorders
04/26/2001CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/25/2001CN1292786A Process for producing simvastatin and/or its derivatives
04/24/2001US6222044 Reacting an aromatic aldehyde with hydroxylamine to form an aromatic aldehyde oxime, halogenating oxime to form aromatic hydroxamoyl halide, and reacting with aromatic amine compounds to form benzoxazole, benzothiaxole, benzimidazoles
04/24/2001US6221914 Sulfonamide bridging compounds that inhibit tryptase activity
04/24/2001US6221892 Heterocyclic topoisomerase poisons
04/24/2001US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase.
04/19/2001WO2001027088A1 Lpl potentiators
04/19/2001WO2000073274A3 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
04/19/2001WO2000018767A9 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
04/19/2001US20010000345 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer
04/18/2001EP1091942A1 Potassium channel blocking agents
04/18/2001EP1091941A1 Novel benzimidazoles as corticotropin release factor antagonists
04/18/2001EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
04/18/2001EP0968250B1 Soluble chromophores having improved solubilising groups
04/18/2001EP0723544B1 ALKOXY ALKYL CARBAMATES OF IMIDAZO[1,2-a]PYRIDINES
04/18/2001EP0579827B1 Method of preparing 2-arylbenzimidazole 5-sulphonic acids
04/18/2001CN1291973A N-sulphonyl and N-sulphinyl phenylglycinamide
04/18/2001CN1291609A Method of preparing 5-lipoxidase inhibitor possessing different heterocyclic ring system
04/17/2001US6218547 1-phenyl-benzimidazole compounds and their use as GABA-a receptor modulators
04/17/2001US6218429 Tricyclic compounds, their production and use
04/17/2001US6218388 Therapy of protein tyrosine kinase mediated cancer, atherosclerosis, restenosis, and psoriasis by administering benzimidazole derivative
04/17/2001US6218359 Treating autoimmune, arthritic, tumor diseases
04/17/2001CA2158457C Naphthalene derivatives
04/12/2001WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
04/12/2001WO2001025189A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
04/12/2001WO2001024785A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases
04/12/2001WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2
04/12/2001DE19948101A1 New substituted aryl- and heteroaryl-alkanes are serine protease and thrombin inhibitors, used for treatment of e.g. deep vein thrombosis or stroke
04/11/2001EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds
04/11/2001EP1089978A1 Process for preparing oximidazoles
04/11/2001CN1064360C Fused imidazo [1,2-alpha] pyridines
04/10/2001US6214883 Benzamidoxime prodrugs as antipneumocystic agents
04/10/2001CA2251636C Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
04/05/2001WO2001023360A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors
04/05/2001WO2001023359A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
04/05/2001WO2000057877A8 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
04/05/2001DE19947457A1 New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter
04/05/2001CA2382892A1 Substituted benzimidazol derivatives, processes for preparing them and their use as pharmaceutical compositions
04/04/2001EP0738263B1 Substituted phenylimidazolidines having antiandrogen activity
04/04/2001CN1290253A Heterocyclic topoisomerase poisons
04/04/2001CN1289766A Penicillene compounds and derivatives therefrom
04/03/2001US6211382 Acylation of 1-amino-1-cyanocyclopentane, cyclization
04/03/2001US6211366 Psychological, nervous system disorders
04/03/2001US6211240 O-benzyl oxime ether derivatives and their use as pesticides
04/03/2001US6211176 α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
03/2001
03/29/2001WO2001021593A1 New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
03/29/2001WO2001021584A1 Tyrosine derivatives
03/29/2001WO2001021160A2 Carboxymide and aniline derivatives as selective inhibitors of pathogens
03/29/2001DE19945810A1 Substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted benzimidazole derivatives, processes for their preparation and their use as medicaments
03/29/2001DE19945787A1 Arylsulfonamid-substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Arylsulfonamide-substituted benzimidazole derivatives, processes for their preparation and their use as medicaments
03/28/2001EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands
03/28/2001EP1086076A1 Sulfonamide inhibitors of aspartyl protease
03/28/2001EP1086065A4 Combinatorial synthesis of multibinding libraries
03/28/2001EP1086065A1 Combinatorial synthesis of multibinding libraries
03/28/2001EP1085895A1 Bradykinin antagonists